SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ZIOPHARM Oncology, Inc. Announces Acceptance of Investigational New Drug Application for ZIN ATI-001 (Ad-RTS-IL-12), a Novel DNA-Based Oncology Therapeutic Candidate